rs140979604

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_025265.4(TSEN2):​c.872A>G​(p.Tyr291Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000147 in 1,612,184 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y291H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 3 hom. )

Consequence

TSEN2
NM_025265.4 missense

Scores

1
8
10

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 2.03

Publications

0 publications found
Variant links:
Genes affected
TSEN2 (HGNC:28422): (tRNA splicing endonuclease subunit 2) This gene encodes one of the subunits of the tRNA splicing endonuclease. This endonuclease catalyzes the first step in RNA splicing which is the removal of introns. Mutations in this gene have been associated with pontocerebellar hypoplasia type 2. A pseudogene has been identified on chromosome 4. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2009]
TSEN2 Gene-Disease associations (from GenCC):
  • pontocerebellar hypoplasia type 2B
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • pontocerebellar hypoplasia type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.031982332).
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000142 (207/1459904) while in subpopulation MID AF = 0.00121 (7/5764). AF 95% confidence interval is 0.000714. There are 3 homozygotes in GnomAdExome4. There are 102 alleles in the male GnomAdExome4 subpopulation. Median coverage is 28. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSEN2NM_025265.4 linkc.872A>G p.Tyr291Cys missense_variant Exon 6 of 12 ENST00000284995.11 NP_079541.1 Q8NCE0-1A0A024R2G3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSEN2ENST00000284995.11 linkc.872A>G p.Tyr291Cys missense_variant Exon 6 of 12 1 NM_025265.4 ENSP00000284995.6 Q8NCE0-1

Frequencies

GnomAD3 genomes
AF:
0.000197
AC:
30
AN:
152162
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00230
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000311
AC:
78
AN:
251194
AF XY:
0.000243
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000925
Gnomad ASJ exome
AF:
0.00208
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000969
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.000142
AC:
207
AN:
1459904
Hom.:
3
Cov.:
28
AF XY:
0.000140
AC XY:
102
AN XY:
726420
show subpopulations
African (AFR)
AF:
0.000479
AC:
16
AN:
33418
American (AMR)
AF:
0.000939
AC:
42
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00218
AC:
57
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39672
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86214
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000495
AC:
55
AN:
1110246
Other (OTH)
AF:
0.000464
AC:
28
AN:
60330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000197
AC:
30
AN:
152280
Hom.:
0
Cov.:
32
AF XY:
0.000121
AC XY:
9
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0000962
AC:
4
AN:
41562
American (AMR)
AF:
0.000392
AC:
6
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00230
AC:
8
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68014
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000197
Hom.:
0
Bravo
AF:
0.000215
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000288
AC:
35
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000296

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Nov 21, 2019
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge -

Nov 27, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 291 of the TSEN2 protein (p.Tyr291Cys). This variant is present in population databases (rs140979604, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with TSEN2-related conditions. ClinVar contains an entry for this variant (Variation ID: 212445). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TSEN2 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Uncertain:1
Apr 14, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pontoneocerebellar hypoplasia Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.091
T
BayesDel_noAF
Uncertain
0.030
CADD
Benign
22
DANN
Benign
0.97
DEOGEN2
Uncertain
0.61
D;.;D;D
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.18
FATHMM_MKL
Benign
0.46
N
LIST_S2
Benign
0.81
T;T;.;T
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.032
T;T;T;T
MetaSVM
Benign
-0.49
T
MutationAssessor
Uncertain
2.4
.;.;M;M
PhyloP100
2.0
PrimateAI
Uncertain
0.56
T
PROVEAN
Pathogenic
-5.7
D;D;D;D
REVEL
Uncertain
0.51
Sift
Uncertain
0.0010
D;D;D;D
Sift4G
Uncertain
0.020
D;D;D;D
Polyphen
0.70
.;.;P;P
Vest4
0.53, 0.59
MVP
0.91
MPC
0.13
ClinPred
0.11
T
GERP RS
2.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.62
gMVP
0.52
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140979604; hg19: chr3-12546693; API